States / Tennessee / SB 421

SB 421 In Committee

Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Compare versions →
Amendment HA0252 — · 359 words Open full page ↗

House Health 1

Amendment No. 1 to HB1239

Terry

Signature of Sponsor

AMEND Senate Bill No. 421* House Bill No. 1239

by deleting all language after the enacting clause and substituting:

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.